0001659617-16-000001.txt : 20160516 0001659617-16-000001.hdr.sgml : 20160516 20160516170320 ACCESSION NUMBER: 0001659617-16-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160516 DATE AS OF CHANGE: 20160516 EFFECTIVENESS DATE: 20160516 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Moleculin Biotech, Inc. CENTRAL INDEX KEY: 0001659617 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474671999 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-263286 FILM NUMBER: 161654920 BUSINESS ADDRESS: STREET 1: 2575 WEST BELLFORT STREET 2: SUITE 333 CITY: HOUSTON STATE: TX ZIP: 77054 BUSINESS PHONE: 713-300-5160 MAIL ADDRESS: STREET 1: 2575 WEST BELLFORT STREET 2: SUITE 333 CITY: HOUSTON STATE: TX ZIP: 77054 D 1 primary_doc.xml X0707 D LIVE 0001659617 Moleculin Biotech, Inc. 2575 WEST BELLFORT SUITE 333 HOUSTON TX TEXAS 77054 713-300-5160 DELAWARE None None Corporation true 2015 Walter Klemp 2575 West Bellfort Suite 333 Houston TX TEXAS 77054 Executive Officer Director Louis Ploth 2575 West Bellfort Suite 333 Houston TX TEXAS 77054 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2016-05-02 false true true 0 6000000 6000000 0 Based on a value of $6.00 per share, which is the public offering price per share in the company's initial public offering commenced on May 2, 2016. false 129 0 0 0 false Moleculin Biotech, Inc. /s/ Louis Ploth Louis Ploth Chief Financial Officer 2016-05-16